Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qianhai Ark Asset Management is a leading Chinese fund of funds manager, established in 2015. It manages nearly CNY 70 billion in assets across various funds, making it the largest commercially raised fund of funds in China. The firm has made 245 investments, with 23 portfolio exits, including IPOs. It invests across sectors including life sciences, information technology, and advanced manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qianhai Ark Asset Management.